Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome

被引:185
|
作者
Lay, JD
Tsao, CJ
Chen, JY
Kadin, ME
Su, IJ
机构
[1] NATL CHENG KUNG UNIV HOSP,DEPT PATHOL,TAINAN 704,TAIWAN
[2] NATL CHENG KUNG UNIV HOSP,DEPT INTERNAL MED,TAINAN 704,TAIWAN
[3] COLL MED,TAINAN 704,TAIWAN
[4] NATL TAIWAN UNIV,COLL MED,GRAD INST MICROBIOL,TAIPEI 100,TAIWAN
[5] NATL TAIWAN UNIV,COLL MED,GRAD INST PATHOL,TAIPEI 100,TAIWAN
[6] BETH ISRAEL DEACONNESS MED CTR,DEPT PATHOL,BOSTON,MA
[7] HARVARD UNIV,SCH MED,BOSTON,MA 02115
来源
JOURNAL OF CLINICAL INVESTIGATION | 1997年 / 100卷 / 08期
关键词
tumor necrosis factor-alpha; Epstein-Barr virus; T/NK cell lymphoma; hemophagocytic syndrome;
D O I
10.1172/JCI119728
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A potentially fatal hemophagocytic syndrome has been noted in patients with malignant lymphomas, particularly in EBV-infected T cell lymphoma, Cytokines, such as interferon-gamma (IFN-gamma), TNF-alpha, and IL-1 alpha, are elevated in patients' sera. To verify whether infection of T cells by EBV will upregulate specific cytokine genes and subsequently activate macrophages leading to hemophagocytic syndrome, we studied the transcripts of TNF-alpha, IFN-gamma, and IL-1 alpha in EBV-infected and EBV-negative lymphoma tissues, By reverse transcription PCR analysis, transcripts of TNF-alpha were detected in 8 (57%) of 14 EBV-infected T cell lymphomas, higher than that detected in EBV-negative T cell lymphoma (one of six, 17%), EBV-positive B cell lymphoma (two of five, 40%) and EBV-negative B cell lymphomas (one of seven, 14%). Transcripts of IFN-gamma were consistently detected in T cell lymphoma and occasionally in B cell lymphoma, but were independent of EBV status. IL-1 alpha expression was not detectable in any category. Consistent with these in vivo observations, in vitro EBV infection of T cell lymphoma lines caused upregulation of TNF-alpha gene, and increased secretion of TNF-alpha, but not IFN-gamma or IL-1 alpha. Expression of TNF-alpha, IFN-gamma, and IL-1 alpha was not changed by EBV infection of B cell lymphoma lines. To identify the specific cytokine(s) responsible for macrophage activation, culture supernatants from EBV-infected T cells were cocultured with a monocytic cell line U937 for 24 h. Enhanced phagocytosis and secretion of TNF-alpha, IFN-gamma, and IL-1 alpha by U937 cells were observed, and could be inhibited to a large extent by anti-TNF-alpha (70%), less effectively by anti-IFN-gamma (31%), but almost completely by the combination of anti-TNF-alpha and anti-IFN-gamma (85%). Taken together, the in vivo and in vitro observations suggest that infection of T cells by EBV selectively upregulates the TNF-alpha expression which, in combination with IFN-gamma and probably other cytokines, can activate macrophages. This study not only highlights a probable pathogenesis for virus-associated hemophagocytic syndrome, but also suggests that anti-TNF-alpha will have therapeutic potential in the context of their fatal syndrome.
引用
收藏
页码:1969 / 1979
页数:11
相关论文
共 50 条
  • [1] Elevated Tumor Necrosis Factor-alpha Expression in Periapical Lesions Infected by Epstein-Barr Virus
    Hernadi, Katinka
    Gyoengyoesi, Eszter
    Meszaros, Beata
    Szakacs, Levente
    Szalmas, Anita
    Csoma, Eszter
    Mogyorosi, Richard
    Czompa, Levente
    Veress, Gyoergy
    Varga, Istvan
    Marton, Ildiko Judit
    Konya, Jozsef
    [J]. JOURNAL OF ENDODONTICS, 2013, 39 (04) : 456 - 460
  • [2] Sequential Quantification of Epstein-Barr Virus DNA in a Case of Epstein-Barr Virus—Associated Hemophagocytic Syndrome
    Toru Takahashi
    Eiichi Oeda
    Yutaka Sato
    Yukio Tanizawa
    [J]. International Journal of Hematology, 2002, 76 : 290 - 291
  • [3] Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome
    Yoshioka, M
    Kikuta, H
    Ishiguro, N
    Endo, R
    Kobayashi, K
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2003, 70 (03) : 410 - 419
  • [4] Sequential quantification of Epstein-Barr virus DNA in a case of Epstein-Barr virus-associated hemophagocytic syndrome
    Takahashi, T
    Oeda, E
    Sato, Y
    Tanizawa, Y
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (03) : 290 - 291
  • [5] Epstein-Barr Virus and Hemophagocytic Lymphohistiocytosis
    Marsh, Rebecca A.
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 8
  • [6] MONOCLONAL PROLIFERATION OF EPSTEIN-BARR VIRUS-INFECTED T-CELLS IN A PATIENT WITH VIRUS-ASSOCIATED HEMOPHAGOCYTIC SYNDROME
    NOMA, T
    KOU, K
    YOSHIZAWA, I
    KAWANO, Y
    MIYASHITA, T
    MIZUTANI, S
    YATA, J
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1994, 153 (10) : 734 - 738
  • [7] Epstein-Barr virus-specific T cells for the management of Epstein-Barr virus lymphomas
    Finberg, RW
    [J]. CURRENT OPINION IN ONCOLOGY, 2001, 13 (05) : 349 - 353
  • [8] Clonal expansion of multiphenotypic Epstein-Barr virus-infected lymphocytes in chronic active Epstein-Barr virus infection
    Endo, R
    Yoshioka, M
    Ebihara, T
    Ishiguro, N
    Kikuta, H
    Kobayashi, K
    [J]. MEDICAL HYPOTHESES, 2004, 63 (04) : 582 - 587
  • [9] EPSTEIN-BARR VIRUS-ASSOCIATED HEMOPHAGOCYTIC SYNDROME
    KIKUTA, H
    [J]. LEUKEMIA & LYMPHOMA, 1995, 16 (5-6) : 425 - 429
  • [10] FAILURE TO DETECT HETEROFIL ANTIGENS IN EPSTEIN-BARR VIRUS-INFECTED CELLS AND TO DEMONSTRATE INTERACTION OF HETEROFIL ANTIBODIES WITH EPSTEIN-BARR VIRUS
    HENLE, W
    HENLE, G
    HEWETSON, J
    ROCCHI, G
    LEIKOLA, J
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1974, 17 (02): : 281 - 286